How to Reconstitute Tesamorelin: Step-by-Step Laboratory Protocol
How to Reconstitute Tesamorelin: Step-by-Step Laboratory Protocol
Tesamorelin represents a synthetic analog of growth hormone-releasing hormone (GHRH) consisting of 44 amino acids with enhanced stability characteristics. This peptide compound demonstrates significant research potential in cellular metabolism studies, particularly in investigations of growth hormone pathway modulation and lipid metabolism mechanisms. Laboratory researchers utilize tesamorelin in vitro models to examine hepatic function, adipocyte behavior, and cellular energy utilization patterns. The lyophilized formulation ensures extended shelf stability while maintaining peptide integrity for precise research applications.
Required Laboratory Materials
Tesamorelin 5mg lyophilized vial from Element SARMs
Bacteriostatic water for injection or sterile water for injection
Precision analytical balance (0.1mg resolution minimum)
Class II biological safety cabinet with laminar airflow
Sterile 1mL or 3mL syringes with Luer-lock connection
Sterile needles (25-gauge, 1-inch length recommended)
70% isopropyl alcohol solution
Sterile alcohol prep pads
Laboratory-grade vortex mixer
Refrigerated storage containers (2-8°C)
Laboratory documentation sheets
Pre-Reconstitution Preparation
Establish proper laboratory conditions by ensuring ambient temperature stabilization between 20-25°C for optimal reconstitution accuracy. Verify biological safety cabinet functionality and UV sterilization completion prior to commencing procedures. Remove tesamorelin vials from refrigerated storage and allow equilibration to room temperature for approximately 15-20 minutes before manipulation. This temperature adjustment prevents thermal shock and maintains peptide structural integrity during solvent addition.
Calculate required solvent volumes based on desired final concentrations using the formula: Volume = Mass ÷ Desired Concentration. Prepare bacteriostatic water or sterile water for injection according to laboratory standards, ensuring sterile technique maintenance throughout preparation phases. Document all calculations and preparation steps in laboratory records for reproducibility and compliance verification.
Step-by-Step Reconstitution Protocol
Step 1: Position the lyophilized tesamorelin vial within the biological safety cabinet and remove the protective cap to expose the rubber stopper. Clean the stopper surface thoroughly using sterile alcohol prep pads with circular motions from center outward.
Step 2: Draw the calculated volume of bacteriostatic water into a sterile syringe, ensuring no air bubbles remain within the syringe barrel. Maintain sterile technique by avoiding needle contact with non-sterile surfaces.
Step 3: Insert the needle through the rubber stopper at a slight angle, directing the needle tip toward the vial wall rather than directly onto the lyophilized powder cake. This approach minimizes foaming and preserves peptide structure.
Step 4: Inject the solvent slowly along the vial wall, allowing gentle flow over the lyophilized material. Avoid creating turbulence or direct impact on the powder, which may cause aggregation or denaturation.
Step 5: Remove the needle and syringe assembly carefully, then gently swirl the vial using circular motions. Avoid vigorous agitation or vortexing, as excessive mechanical stress may compromise peptide integrity.
Step 6: Allow complete dissolution to occur naturally, typically requiring 2-5 minutes for full reconstitution. The resulting solution should appear clear and colorless without visible particulates or cloudiness.
Concentration Options
1.0 mL
5.0 mg/mL
High-concentration stock preparation
2.0 mL
2.5 mg/mL
Standard working concentration
5.0 mL
1.0 mg/mL
Dilute research applications
Storage Conditions and Stability
Store reconstituted tesamorelin solutions under refrigerated conditions at 2-8°C to maintain optimal stability and biological activity. Protect solutions from direct light exposure by utilizing amber vials or aluminum foil wrapping. Reconstituted peptides demonstrate maximum stability when stored in bacteriostatic water, typically maintaining activity for 14-21 days under proper conditions.
Avoid freeze-thaw cycles, which may cause peptide aggregation and loss of biological activity. For extended storage requirements beyond 21 days, consider preparing multiple smaller volume aliquots to minimize repeated access to stock solutions. Monitor solutions regularly for signs of precipitation, color changes, or unusual odors that may indicate degradation.
Research Application Notes
Element SARMs provides tesamorelin with verified purity specifications exceeding 98% for consistent research outcomes. Laboratory applications include growth hormone pathway studies, metabolic research protocols, and cellular signaling investigations. Researchers should consider peptide stability characteristics when designing experimental timelines and storage protocols for optimal research results.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
Hexarelin
TB-500
Epithalon
Ipamorelin
Tirzepatide
CJC-1295 DAC
PT-141
Semaglutide
Selank
BPC-157
Sermorelin
Melanotan 2
IGF LR3
Tesamorelin
AICAR
IGF-DES
GHRP 2
Albuterol
Tamoxifen
Letrozole
Clomiphene
Tadalafil
Clenbuterol
Anastrozole
Finasteride
Exemestane
Sildenafil
Yohimbine
Bacteriostatic Water Recent Posts Melanotan 2 (MT2): Mechanism, Research, and Safety Considerations Ipamorelin: The Selective GHRP, Explained Tesamorelin: The GHRH Analog Studied for Visceral Fat Sermorelin: The Original GHRH Analog, Explained CJC-1295: How the GHRH Analog Works, and What Research Shows
Already a customer? Sign In
Create Account
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
Sarms
Stacks
Research Liquids
Albuterol 5MG/ML | 30ML with dropper
Anastrozole 1.5MG/ML | 30ML with dropper
Clomiphene 50MG/ML | 30ML with dropper
Finasteride 5MG/ML | 30ML with dropper
Letrozole 3.5 MG/ML | 30ML with dropper
LiquiCia 30MG/ML | 30ML with dropper
LiquiCia T50 50MG/ML | 30ML with dropper
LiquiClen 200MCG/ML | 30ML with dropper
Liquistane / Exemestane 25MG/ML | 30ML with dropper
LiquiTamo 20MG/ML | 30ML with dropper
LiquiVia 25MG/ML | 30 ML with dropper
T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper
Toremifene Citrate 60MG/ML | 30ML with dropper
Yohimbine HCL 10MG/ML | 30ML with dropper
Research Peptides
Aicar 50MG
BPC-157 + TB-500 Blend 2mg ea/ 4MG
BPC-157 5MG
CJC-1295 + DAC 2MG
CJC-1295 | No DAC 2MG
Epithalon 10MG
Frag Premium 176-191 5MG
GHK-CU Copper Peptide 50MG
GHRP-2 5MG
GHRP-6 5MG
Hexarelin 5MG
IGF-1 DES 1MG
IGF-1 LR3 1MG
Ipamorelin 5MG
Melanotan 2 10MG
NAD+ 500MG
PT-141 / Bremelanotide 10MG
GLP-1/GIP/GCG (RT)
Selank 5MG
GLP1 (SM)
Sermorelin 5MG
TB-500 5MG
GIP/GLP-1 (TZ)
PDE5 Inhibitors
GLP-1
Diluents
Bacteriostatic Water 10ML